# Integrated Oncology (United States)

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/integrated-oncology-united-states/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 80.3 |
| Citations | 255,967 |
| City | Durham |
| Country | US |
| Description | Integrated Oncology (United States) is a research organisation in Durham, US. OpenAlex records 2,629 works and 255,967 citations for it. 1,024 researchers list it as their most recent affiliation. |
| Homepage | http://www.integratedoncology.com/ |
| OpenAlex ID | https://openalex.org/I4210094797 |
| Region | North Carolina |
| Researchers | 1,024 |
| ROR ID | https://ror.org/00w8byr45 |
| Type | company |
| Works | 2,629 |

## University papers

- [Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial](https://scholariq.org/papers/docetaxel-plus-nintedanib-versus-docetaxel-plus-placebo-in-patients-with/)
- [Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer: a JSMO–ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOS](https://scholariq.org/papers/pan-asian-adapted-esmo-consensus-guidelines-for-the-management-of-patients-with/)
- [Randomized Phase III Placebo-Controlled Trial of Carboplatin and Paclitaxel With or Without the Vascular Disrupting Agent Vadimezan (ASA404) in Advanced Non–Small-Cell Lung Cancer](https://scholariq.org/papers/randomized-phase-iii-placebo-controlled-trial-of-carboplatin-and-paclitaxel-with/)

## University top topics

Showing 8 of 25.

- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Glioma Diagnosis and Treatment](https://scholariq.org/topics/glioma-diagnosis-and-treatment/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.